BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 20062935)

  • 1. High incidence of in-hospital pulmonary embolism following joint arthroplasty with dalteparin prophylaxis.
    Kerr J; Linkins LA
    Thromb Haemost; 2010 Jan; 103(1):123-8. PubMed ID: 20062935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of clinical pulmonary embolism after joint surgery in patients receiving low-molecular-weight heparin prophylaxis in hospital: a 10-year prospective register of 3,954 patients.
    Dahl OE; Gudmundsen TE; Bjørnarå BT; Solheim DM
    Acta Orthop Scand; 2003 Jun; 74(3):299-304. PubMed ID: 12899550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-molecular-weight heparin (dalteparin) in women with gynecologic malignancy.
    DeBernardo RL; Perkins RB; Littell RD; Krasner CN; Duska LR
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1006-11. PubMed ID: 15863537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dose-ranging study of the oral direct thrombin inhibitor, ximelagatran, and its subcutaneous form, melagatran, compared with dalteparin in the prophylaxis of thromboembolism after hip or knee replacement: METHRO I. MElagatran for THRombin inhibition in Orthopaedic surgery.
    Eriksson BI; Arfwidsson AC; Frison L; Eriksson UG; Bylock A; Kälebo P; Fager G; Gustafsson D
    Thromb Haemost; 2002 Feb; 87(2):231-7. PubMed ID: 11858482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.
    Abad JI; Gómez-Outes A; Martínez-González J; Rocha E;
    Arch Orthop Trauma Surg; 2007 Oct; 127(8):665-70. PubMed ID: 17089172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.
    Wåhlander K; Larson G; Lindahl TL; Andersson C; Frison L; Gustafsson D; Bylock A; Eriksson BI
    Thromb Haemost; 2002 Apr; 87(4):580-5. PubMed ID: 12008938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dalteparin versus enoxaparin for venous thromboembolism prophylaxis in acute spinal cord injury and major orthopedic trauma patients: 'DETECT' trial.
    Slavik RS; Chan E; Gorman SK; de Lemos J; Chittock D; Simons RK; Wing PC; Ho SG
    J Trauma; 2007 May; 62(5):1075-81; discussion 1081. PubMed ID: 17495705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
    Bell GK; Goldhaber SZ
    Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-institutional study of symptomatic deep venous thrombosis and pulmonary embolism in prostate cancer patients undergoing laparoscopic or robot-assisted laparoscopic radical prostatectomy.
    Secin FP; Jiborn T; Bjartell AS; Fournier G; Salomon L; Abbou CC; Haber GP; Gill IS; Crocitto LE; Nelson RA; Cansino Alcaide JR; Martínez-Piñeiro L; Cohen MS; Tuerk I; Schulman C; Gianduzzo T; Eden C; Baumgartner R; Smith JA; Entezari K; van Velthoven R; Janetschek G; Serio AM; Vickers AJ; Touijer K; Guillonneau B
    Eur Urol; 2008 Jan; 53(1):134-45. PubMed ID: 17597288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inpatient and outpatient occurrence of deep vein thrombosis and pulmonary embolism and thromboprophylaxis following selected at-risk surgeries.
    Amin AN; Lin J; Thompson S; Wiederkehr D
    Ann Pharmacother; 2011 Sep; 45(9):1045-52. PubMed ID: 21862717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatic thromboembolism after one-stage bilateral THA with a multimodal prophylaxis protocol.
    Beksaç B; González Della Valle A; Anderson J; Sharrock NE; Sculco TP; Salvato EA
    Clin Orthop Relat Res; 2007 Oct; 463():114-9. PubMed ID: 17960674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative deep vein thrombosis prophylaxis: a retrospective analysis in 1000 consecutive hip fracture patients treated in a community hospital setting.
    Ennis RS
    J South Orthop Assoc; 2003; 12(1):10-7. PubMed ID: 12735619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended dalteparin prophylaxis for venous thromboembolic events: cost-utility analysis in patients undergoing major orthopedic surgery.
    Dranitsaris G; Stumpo C; Smith R; Bartle W
    Am J Cardiovasc Drugs; 2009; 9(1):45-58. PubMed ID: 19178131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.
    Leizorovicz A; Cohen AT; Turpie AG; Olsson CG; Vaitkus PT; Goldhaber SZ;
    Circulation; 2004 Aug; 110(7):874-9. PubMed ID: 15289368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
    Whang PG; Lieberman JR
    Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence and prevention of symptomatic thromboembolic disease following unicompartmental knee arthroplasty.
    Lombardi AV; Berend KR; Tucker TL
    Orthopedics; 2007 May; 30(5 Suppl):46-8. PubMed ID: 17549868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of Venous Thromboembolism after Arthroscopic Knee Surgery in a Low-Risk Population with the Use of Aspirin. A Randomized Trial.
    Kaye ID; Patel DN; Strauss EJ; Alaia MJ; Garofolo G; Martinez A; Jazrawi LM
    Bull Hosp Jt Dis (2013); 2015 Dec; 73(4):243-8. PubMed ID: 26630467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of illness in venous thromboembolism in critical care: a multicenter observational study.
    Patel R; Cook DJ; Meade MO; Griffith LE; Mehta G; Rocker GM; Marshall JC; Hodder R; Martin CM; Heyland DK; Peters S; Muscedere J; Soth M; Campbell N; Guyatt GH; ;
    J Crit Care; 2005 Dec; 20(4):341-7. PubMed ID: 16310605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
    Haentjens P; De Groote K; Annemans L
    Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.